Cancer research discovery shows promising results in diabetes prevention and treatment

In a groundbreaking discovery, Mayo Clinic researchers have identified a molecule, ST8Sia6, typically used by cancer cells to evade the immune system, as a potential treatment for type 1 diabetes. By engineering pancreatic beta cells to produce this molecule, they created a sugar coating that shielded the cells from immune attack in lab models.